Compound information
- Natural Products
- ZC72706
- Molecular Formula
- C10H8N2O2
- Molecular Weight
- 188.058577496 g/mol
- Structure
-
- IUPAC Name
- 1-(4-pyridylmethyl)pyrrole-2,5-dione
- InChI
- InChI=1S/C10H8N2O2/c13-9-1-2-10(14)12(9)7-8-3-5-11-6-4-8/h1-6H,7H2
- InChI Key
- DLCDGDBHDUBEPC-UHFFFAOYSA-N
- SMILES
- O=C1C=CC(=O)N1Cc1ccncc1
- Source
- ZINC000013205156
Warheads
- Acrylamide
-
- Acrylamide
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 14 | Ring Count | 2 |
Heteroatom Count | 4 | Rotatable Bond Count | 2 |
Hydrogen Bond Acceptor Count | 3 | Hydrogen Bond Donor Count | 0 |
Topological Polar Surface Area | 50.27 Å2 | LogP | 0.487 |
LogS | -1.749 | LogD | 0.089 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.051 | Pgp substrate | 0.008 |
HIA | 0.961 | F20 % | 0.992 |
F30 % | 0.859 | Caco-2 | -4.669 |
MDCK | -4.453 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.999 | PPB | 52.165 |
VD | 0.646 | Fu | 0.361 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.995 | CYP1A2 substrate | 0.633 |
CYP2A6 substrate | 0.537 | CYP2B6 substrate | 0.621 |
CYP2C19 inhibitor | 0.139 | CYP2C19 substrate | 0.741 |
CYP2C8 substrate | 0.674 | CYP2C9 inhibitor | 0.863 |
CYP2C9 substrate | 0.853 | CYP2D6 inhibitor | 0.061 |
CYP2D6 substrate | 0.43 | CYP2E1 substrate | 0.606 |
CYP3A4 inhibitor | 0.055 | CYP3A4 substrate | 0.746 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.744 | CL | 5.703 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.003 | Hepatotoxicity | 0.597 |
Mutagenicity | 0.006 | Rat Oral Acute Toxicity | 0.736 |
FDAMDD | 0.273 | Skin Sensitization | 0.995 |
Carcinogenicity | 0.318 | Eye Corrosion | 0.003 |
Eye Irritation | 0.92 | Respiratory Toxicity | 0.327 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.81 | IGC50 | 3.32 |
LC50FM | 2.58 | LC50DM | 3.705 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.109 | NR-AR-LBD | 0.301 |
NR-AhR | 0.042 | NR-Aromatase | 0.212 |
NR-ER | 0.203 | NR-ER-LBD | 0.397 |
NR-PPAR-gamma | 0.826 | SR-ARE | 0.903 |
SR-ATAD5 | 0.647 | SR-HSE | 0.932 |
SR-MMP | 0.025 | SR-p53 | 0.644 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.